NCT02905682View on ClinicalTrials.gov

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

September 27, 2017

Study Completion Date

September 27, 2017

Conditions
Nocturia
Interventions
DRUG

Desmopressin

DRUG

Placebo

Trial Locations (1)

Unknown

Investigational site (there may be other sites in this country), Tokyo

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT02905682 - Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects | Biotech Hunter | Biotech Hunter